Mammalian target of rapamycin inhibition as therapy for hematologic malignancies (multiple letters)

Corey Cutler; Joseph H. Antin; Francis J. Giles

doi:10.1002/cncr.20495

Mammalian target of rapamycin inhibition as therapy for hematologic malignancies (multiple letters)

Corey Cutler^*, Joseph H. Antin, Francis J. Giles

^*Corresponding author for this work

Medicine, Hematology Oncology Division

Research output: Contribution to journal › Letter › peer-review

5 Scopus citations

Original language	English (US)
Pages (from-to)	1478
Number of pages	1
Journal	cancer
Volume	101
Issue number	6
DOIs	https://doi.org/10.1002/cncr.20495
State	Published - Sep 15 2004

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1002/cncr.20495

Cite this

@article{905ebcef27df42b5b1a1b03806954fb6,

title = "Mammalian target of rapamycin inhibition as therapy for hematologic malignancies (multiple letters)",

author = "Corey Cutler and Antin, {Joseph H.} and Giles, {Francis J.}",

year = "2004",

month = sep,

day = "15",

doi = "10.1002/cncr.20495",

language = "English (US)",

volume = "101",

pages = "1478",

journal = "cancer",

issn = "0008-543X",

publisher = "John Wiley and Sons Inc.",

number = "6",

}

TY - JOUR

T1 - Mammalian target of rapamycin inhibition as therapy for hematologic malignancies (multiple letters)

AU - Cutler, Corey

AU - Antin, Joseph H.

AU - Giles, Francis J.

PY - 2004/9/15

Y1 - 2004/9/15

UR - http://www.scopus.com/inward/record.url?scp=4444258766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444258766&partnerID=8YFLogxK

U2 - 10.1002/cncr.20495

DO - 10.1002/cncr.20495

M3 - Letter

C2 - 15368336

AN - SCOPUS:4444258766

SN - 0008-543X

VL - 101

SP - 1478

JO - cancer

JF - cancer

IS - 6

ER -

Mammalian target of rapamycin inhibition as therapy for hematologic malignancies (multiple letters)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this